Hypercholesterolemia Paradox in Relation to Mortality in Acute Coronary Syndrome
Key result
A history of hypercholesterolemia was associated with lower in-hospital mortality in patients with non-ST-segment elevation ACS (adjusted OR 0.74; 95% CI 0.68-0.80).
Why the study?
Does a history of hypercholesterolemia or newly diagnosed hypercholesterolemia affect in-hospital mortality in patients with non-ST-segment elevation ACS?
Population
84,429 patients with non-ST-segment elevation acute coronary syndromes (ACS) from the CRUSADE registry
Comparison
History of hypercholesterolemia or newly… vs No history of hypercholesterolemia or normal LDL…
Design
Cohort
Follow-up
in-hospital
Authors
Discussion
Loading...
Member takes
Implication
The cholesterol paradox in NSTE-ACS warrants cautious interpretation; leaves open causality and risk-stratification implications.
Key Points
- This research investigates the unexpected relationship between hypercholesterolemia and reduced mortality in acute coronary syndrome patients.
- Analyzed 84,429 patients with non-ST-segment elevation acute coronary syndrome.
- Examined mortality associated with hypercholesterolemia history and newly diagnosed levels during hospitalization.
- Adjusted for clinical covariates and prior statin use in the analysis.
- History of hypercholesterolemia linked to lower in-hospital mortality (OR: 0.71; 95% CI: 0.66, 0.76).
- Protective association remained after multivariable adjustment, including prior statin use (OR: 0.74; 95% CI: 0.68, 0.80).
- New in-hospital hypercholesterolemia showed lower mortality but not significant after adjustment (OR: 0.86; 95% CI: 0.73, 1.01).
Study Design
Type
Observational (n=84,429)
Structured PICO
Does a history of hypercholesterolemia or newly diagnosed hypercholesterolemia affect in-hospital mortality in patients with non-ST-segment elevation ACS?
P
Population
84,429 patients with non-ST-segment elevation acute coronary syndromes evaluated for the association between hypercholesterolemia and in-hospital mortality.
E
Exposure
History of hypercholesterolemia or newly diagnosed hypercholesterolemia (in-hospital low-density lipoprotein cholesterol [LDL-C] >= 100 mg/dL)
C
Comparator
No history of hypercholesterolemia or normal LDL levels
O
Outcome
In-hospital mortalityhard clinical
Main Result
Odds Ratio: 0.74 (95% CI 0.68–0.8)
The 'hypercholesterolemia paradox' in ACS (where hypercholesterolemia appears protective against mortality) is likely an artifact of observational confounding, driven by prior statin use and greater prior medical contact.
Limitations
- Confounding due to other clinical characteristics
- Impact of statin treatment
- Previously diagnosed hypercholesterolemia is a marker for patients with more prior medical contact
Cite This Study
Wang et al. (2009) conducted an observational in Non-ST-segment elevation acute coronary syndromes (ACS) (n=84,429). History of hypercholesterolemia vs. No history of hypercholesterolemia was evaluated on In-hospital mortality (OR 0.74, 95% CI 0.68-0.80). A history of hypercholesterolemia was associated with lower in-hospital mortality in patients with non-ST-segment elevation ACS (adjusted OR 0.74; 95% CI 0.68-0.80).